Home LiteratureArticle Details
PMID: 6252288 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo.

The Journal of general virology ·Vol. 49 ·No. 1 ·1980-07-00 ·Pages 215-20

Jones CL, Holland JJ

Abstract

In contrast to biologically active DI particles, neither u.v.-inactivated standard virus nor either of two different homologous u.v.-inactivated DI particles showed any prophylactic effect when injected intracerebrally into mice concomitantly challenged with VSV. Although u.v.-inactivated DI particles did not prevent death when given with the challenge virus, they did significantly lengthen the time until death occurred. Also, both u.v.-inactivated standard virus and DI particles protected mice against late challenge (at 3 or 10 days after treatment). Dosage titrations of preparations of two different active DI particles showed significant prophylaxis against simultaneous challenge with numbers of DI particles 10- to 100-fold lower than those which gave no prophylaxis when u.v.-inactivated. Thus, prophylaxis in this system in this system required biologically active DI particles.

MeSH Terms
Animals Antigens, Viral Defective Viruses/immunology,physiology Mice Stomatitis/prevention & control Vesicular stomatitis Indiana virus/immunology,physiology Viral Interference Virus Diseases/prevention & control
Chemicals
Antigens, Viral
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Jones C L
Holland J J
Article Info
Journal
The Journal of general virology
Abbr.
J Gen Virol
ISSN
0022-1317
Published
1980-07-00
Pages
215-20
Language
English
Region
England
NLM ID
0077340
Subset
IM
Grants
NIAID NIH HHS · AI 14627 · United States
NCI NIH HHS · CA 05274 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com